{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:55:17Z","timestamp":1790661317826,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.autrev.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T21:07:46Z","timestamp":1499548066000},"page":"946-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis"],"prefix":"10.1016","volume":"16","author":[{"given":"Silvia Martina","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Santaguida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Virili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ruffilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Centanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"c3780","DOI":"10.1136\/bmj.c3780","article-title":"Vitiligo","volume":"341","author":"Viles","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2017.07.006_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","article-title":"The genetics of general'ized vitiligo and associated autoimmune diseases","volume":"20","author":"Spritz","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ced.12771","article-title":"Positivity rates of antithyroid antibody, antinuclear antibody and thyroid peroxidase antibody in different types of vitiligo","volume":"41","author":"Lim","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0040","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/jid.2014.529","article-title":"Simvastatin prevents and reverses depigmentation in a mouse model of Vitiligo","volume":"135","author":"Agarwal","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.006_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Taieb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2265.1986.tb01658.x","article-title":"Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)?","volume":"24","author":"Martino","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-06-0591","article-title":"Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis","volume":"156","author":"Antonelli","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/08916930802170401","article-title":"High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis","volume":"41","author":"Antonelli","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2017.07.006_bb0080","first-page":"1809","article-title":"Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis","volume":"35","author":"Antonelli","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0085","article-title":"Human Th1 dichotomy: origin, phenotype and biologic activities","author":"Annunziato","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.84.9.2868","article-title":"Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells","volume":"84","author":"Luster","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.07.006_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0100","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in Vitiligo patients and CXCL10 as a potential clinical marker for Vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.07.006_bb0105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.5401","article-title":"Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy","volume":"93","author":"Antonelli","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.autrev.2017.07.006_bb0110","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2006-1571","article-title":"Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter","volume":"92","author":"Antonelli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2017.07.006_bb0115","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.1210\/jc.2010-0923","article-title":"CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes","volume":"95","author":"Antonelli","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.metabol.2008.04.023","article-title":"Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis","volume":"57","author":"Antonelli","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2017.07.006_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2008.01.002","article-title":"High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis","volume":"42","author":"Antonelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1210\/jc.2010-2905","article-title":"Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis","volume":"96","author":"Antonelli","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.metabol.2009.10.010","article-title":"Prevalence of thyroid dysfunctions in systemic lupus erythematosus","volume":"59","author":"Antonelli","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/jhg.2015.100","article-title":"Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism","volume":"60","author":"Miyadera","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.autrev.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm.3897","article-title":"Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies","volume":"21","author":"Cho","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.07.006_bb0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","article-title":"Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study","volume":"25","author":"Antonelli","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.autrev.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2004.10.007","article-title":"Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues","volume":"41","author":"Zignego","year":"2004","journal-title":"J Hepatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T09:46:09Z","timestamp":1719308769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1568997217301775"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}